SOLARA.NS

Solara Active Pharma Sciences Limited [SOLARA.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SOLARA.NS Stock Summary

Top 10 Correlated Stocks

SOLARA.NS


In the News

SOLARA.NS Financial details

Company Rating
Strong Buy
Market Cap
11.97B
Income
-324.9M
Revenue
15.53B
Book val./share
406.79
Cash/share
5.83
Dividend
-
Dividend %
-
Employees
2.36K
Optionable
No
Shortable
Yes
Earnings
23 Jan 2024
P/E
-36.81
Forward P/E
46.17
PEG
8.33
P/S
0.77
P/B
0.82
P/C
57.02
P/FCF
23930.34
Quick Ratio
0.5
Current Ratio
1.03
Debt / Equity
0.67
LT Debt / Equity
0.13
-
-
EPS (TTM)
-9.03
EPS next Y
7.2
EPS next Q
-
EPS this Y
-61.93%
EPS next Y
-179.73%
EPS next 5Y
-363.57%
EPS last 5Y
NAN%
Revenue last 5Y
1.78%
Revenue Q/Q
20.7%
EPS Q/Q
-12.15%
-
-
-
-
SMA20
2.32%
SMA50
-6.42%
SMA100
-12.11%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-4%
ROC
0.03%
Gross Margin
46%
Oper. Margin
4%
Profit Margin
-2%
Payout
-
Shs Outstand
36M
Shs Float
15.2M
-
-
-
-
Target Price
-
52W Range
286.0-495.0
52W High
-32.85%
52W Low
+16.22%
RSI
47.29
Rel Volume
0.28
Avg Volume
134.03K
Volume
37.58K
Perf Week
-0.64%
Perf Month
9.56%
Perf Quarter
-13.1%
Perf Half Y
-6.14%
-
-
-
-
Beta
0.946
-
-
Volatility
2.45%, 11.37%
Prev Close
-0.6%
Price
332.4
Change
-1.35%

SOLARA.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
535.49489.84491.07342.4401.17
Net income per share
24.1144.2969-16.18-6.16
Operating cash flow per share
64.7594.3748.45-67.3443.41
Free cash flow per share
43.47-9.53-5.93-125.3912.49
Cash per share
2.5127.5370.5315.86.15
Book value per share
387.16419.62495.06424.29416.84
Tangible book value per share
202.01244.55357.67304.44300.92
Share holders equity per share
387.16419.62495.06424.29416.84
Interest debt per share
247.55305.14218.45307.36306.45
Market cap
11.08B11.5B44.7B23.94B11.79B
Enterprise value
15.7B18.16B48.93B33.85B21.83B
P/E ratio
18.6110.0420.19-41.17-53.16
Price to sales ratio
0.840.912.841.950.82
POCF ratio
6.934.7128.76-9.897.54
PFCF ratio
10.32-46.67-235.03-5.3126.22
P/B Ratio
1.161.062.811.570.79
PTB ratio
1.161.062.811.570.79
EV to sales
1.191.433.112.751.51
Enterprise value over EBITDA
6.996.7211.9932.3613.95
EV to operating cash flow
9.827.4431.48-13.9913.97
EV to free cash flow
14.63-73.69-257.27-7.5148.57
Earnings yield
0.050.10.05-0.02-0.02
Free cash flow yield
0.1-0.020-0.190.04
Debt to equity
0.560.660.390.680.68
Debt to assets
0.270.340.240.350.35
Net debt to EBITDA
2.062.461.049.476.42
Current ratio
10.921.341.161.08
Interest coverage
2.072.563.55-0.390.31
Income quality
2.772.130.72.66-3.49
Dividend Yield
00.01000
Payout ratio
00.110.09-0.190
Sales general and administrative to revenue
0.010.020.020.030.16
Research and developement to revenue
00.050.040.050.03
Intangibles to total assets
0.240.210.170.150.14
Capex to operating cash flow
-0.33-1.1-1.120.86-0.71
Capex to revenue
-0.04-0.21-0.11-0.17-0.08
Capex to depreciation
-0.63-2.86-1.61-1.86-1
Stock based compensation to revenue
00000
Graham number
458.29646.64876.68393.02240.36
ROIC
0.10.090.13-0.010.01
Return on tangible assets
0.040.070.1-0.02-0.01
Graham Net
-248.97-243.84-69.59-185.61-185.67
Working capital
-9.42M-579M2.69B1.68B864.2M
Tangible asset value
4.99B6.33B11.48B10.94B10.83B
Net current asset value
-3.45B-3.91B368.1M-1.86B-2.09B
Invested capital
0.560.660.390.680.68
Average receivables
1.79B3.27B4.3B5.58B5.61B
Average payables
2.79B2.3B2.63B2.96B2.95B
Average inventory
2.04B2.5B2.87B4.35B5.67B
Days sales outstanding
98.9184.89130.87163.63144
Days payables outstanding
119.45123.12146.7148.32141.53
Days of inventory on hand
107.73159.35139.9301.06258.24
Receivables turnover
3.694.32.792.232.53
Payables turnover
3.062.962.492.462.58
Inventory turnover
3.392.292.611.211.41
ROE
0.060.110.14-0.04-0.01
Capex per share
-21.28-103.9-54.38-58.05-30.93

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q2

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
94.1105.27105.6597.85118.2
Net income per share
-2.770.121.05-5.43-4.77
Operating cash flow per share
000.0100
Free cash flow per share
000.0100
Cash per share
2.6606.1405.83
Book value per share
416.720416.410406.79
Tangible book value per share
298.630300.610292.45
Share holders equity per share
416.720416.410406.79
Interest debt per share
276.766.3287.236.84280.55
Market cap
14.98B16.13B11.8B13.73B12.85B
Enterprise value
24.68B16.13B21.84B13.73B22.63B
P/E ratio
-37.6896.2578.23-17.56-18.72
Price to sales ratio
4.434.093.13.93.02
POCF ratio
0023.59K00
PFCF ratio
0023.59K00
P/B Ratio
100.7900.88
PTB ratio
100.7900.88
EV to sales
7.294.095.743.95.32
Enterprise value over EBITDA
78.8830.9240.8664.958.32
EV to operating cash flow
0043.68K00
EV to free cash flow
0043.68K00
Earnings yield
-0.0100-0.01-0.01
Free cash flow yield
00000
Debt to equity
0.6500.6800.67
Debt to assets
0.3400.3500.34
Net debt to EBITDA
31018.79025.21
Current ratio
1.0601.0801.03
Interest coverage
0.121.021.23-0.280.52
Income quality
000.0100
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0000.030
Intangibles to total assets
0.1500.1400.14
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
161.16099.020208.95
ROIC
000.0100.01
Return on tangible assets
0000-0.01
Graham Net
-200.560-185.480-191.55
Working capital
625.6M32.4M864.2M88.9M295.7M
Tangible asset value
10.74B010.83B010.52B
Net current asset value
-2.3B32.4M-2.09B88.9M-2.14B
Invested capital
0.6500.6800.67
Average receivables
2.4B2.4B2.85B2.85B2.8B
Average payables
1.44B1.44B1.53B1.53B1.74B
Average inventory
2.74B2.74B2.79B2.79B2.78B
Days sales outstanding
127.880134.690118.69
Days payables outstanding
136.90143.050131.86
Days of inventory on hand
260.490261.020211
Receivables turnover
0.700.6700.76
Payables turnover
0.6600.6300.68
Inventory turnover
0.3500.3400.43
ROE
-0.01000-0.01
Capex per share
00000

SOLARA.NS Frequently Asked Questions

What is Solara Active Pharma Sciences Limited stock symbol ?

Solara Active Pharma Sciences Limited is a IN stock and trading under the symbol SOLARA.NS

What is Solara Active Pharma Sciences Limited stock quote today ?

Solara Active Pharma Sciences Limited stock price is $332.4 today.

Is Solara Active Pharma Sciences Limited stock public?

Yes, Solara Active Pharma Sciences Limited is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks